Literature DB >> 9327134

Water-soluble polyion complex associates of DNA and poly(ethylene glycol)-poly(L-lysine) block copolymer.

S Katayose1, K Kataoka.   

Abstract

Complex formation of poly(ethylene glycol)-poly(L-lysine) (PEG-PLL) AB type block copolymer with salmon testes DNA or Col E1 plasmid DNA in aqueous milieu was studied. The PLL segment of PEG-PLL interacts with nucleic acid through an electrostatic force to form a water-soluble complex associate with a diameter of ca. 50 nm. PEG segments surrounding the core of the polyion complex prevented the complex from precipitation even under stoichiometric conditions, at which the unit ratio of L-lysine in PEG-PLL and phosphate in the DNA is equal. The profile of the thermal melting curve revealed a higher stabilization of DNA structure in PEG-PLL/DNA complexes compared to that in the complex made from DNA and PLL homopolymer with the same molecular weight as the PLL segment in PEG-PLL. This stabilizing effect on the DNA structure may be due to the compartmentalization of DNA into the microenvironment of PEG with low permittivity. The reversible nature of the PEG-PLL/DNA complex was further verified through the addition of polyanion [poly-(L-aspartic acid)]: Poly(L-aspartic acid) replaced DNA in the complex with PEG-PLL, resulting in the release of free DNA in the medium. Furthermore, the PEG-PLL/DNA complex showed high resistance against DNase I attack, suggesting DNA protection through the segregation into the core of the associate having PEG palisade.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9327134     DOI: 10.1021/bc9701306

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  36 in total

1.  Long term stability of poly((2-dimethylamino)ethyl methacrylate)-based gene delivery systems.

Authors:  J Y Cherng; H Talsma; D J Crommelin; W E Hennink
Journal:  Pharm Res       Date:  1999-09       Impact factor: 4.200

2.  Systemic administration of TerplexDNA system: pharmacokinetics and gene expression.

Authors:  L Yu; H Suh; J J Koh; S W Kim
Journal:  Pharm Res       Date:  2001-09       Impact factor: 4.200

3.  Spectral study of interaction between poly(L-lysine)-poly(ethylene glycol)-poly(L-lysine) and nucleic acids.

Authors:  Yu He; Qiujun Yan; Gongwu Song; Juan Chen
Journal:  J Mater Sci Mater Med       Date:  2011-04-23       Impact factor: 3.896

Review 4.  Polymer architecture and drug delivery.

Authors:  Li Yan Qiu; You Han Bae
Journal:  Pharm Res       Date:  2006-01-11       Impact factor: 4.200

Review 5.  Advances in Biomaterials for Drug Delivery.

Authors:  Owen S Fenton; Katy N Olafson; Padmini S Pillai; Michael J Mitchell; Robert Langer
Journal:  Adv Mater       Date:  2018-05-07       Impact factor: 30.849

Review 6.  Regulatable gene expression systems for gene therapy applications: progress and future challenges.

Authors:  S Goverdhana; M Puntel; W Xiong; J M Zirger; C Barcia; J F Curtin; E B Soffer; S Mondkar; G D King; J Hu; S A Sciascia; M Candolfi; D S Greengold; P R Lowenstein; M G Castro
Journal:  Mol Ther       Date:  2005-08       Impact factor: 11.454

7.  Evaluation of polymerized rosin for the formulation and development of transdermal drug delivery system: a technical note.

Authors:  Prashant M Satturwar; Suniket V Fulzele; Avinash K Dorle
Journal:  AAPS PharmSciTech       Date:  2005-12-27       Impact factor: 3.246

Review 8.  Regulatable gene expression systems for gene therapy.

Authors:  Nuria Vilaboa; Richard Voellmy
Journal:  Curr Gene Ther       Date:  2006-08       Impact factor: 4.391

9.  Synthesis and characterization of ionic charged water soluble arginine-based poly(ester amide).

Authors:  Jun Wu; Martha A Mutschler; Chih-Chang Chu
Journal:  J Mater Sci Mater Med       Date:  2011-02-03       Impact factor: 3.896

Review 10.  Polymeric micelles from poly(ethylene glycol)-poly(amino acid) block copolymer for drug and gene delivery.

Authors:  Kensuke Osada; R James Christie; Kazunori Kataoka
Journal:  J R Soc Interface       Date:  2009-04-01       Impact factor: 4.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.